scispace - formally typeset
T

Teresa C.P. Dinis

Researcher at University of Coimbra

Publications -  49
Citations -  5277

Teresa C.P. Dinis is an academic researcher from University of Coimbra. The author has contributed to research in topics: Antioxidant & Peroxynitrite. The author has an hindex of 28, co-authored 48 publications receiving 4730 citations.

Papers
More filters
Journal ArticleDOI

Action of Phenolic Derivatives (Acetaminophen, Salicylate, and 5-Aminosalicylate) as Inhibitors of Membrane Lipid Peroxidation and as Peroxyl Radical Scavengers

TL;DR: 5-Aminosalicylate reacts promptly with DPPH, suggesting a potent radical scavenger activity and was found to be the most active in inhibiting Fe2+/ascorbate-induced lipid peroxidation, suggesting an antioxidant activity of chain-breaking type.
Journal ArticleDOI

Antioxidant activities of some extracts of Thymus zygis

TL;DR: There is a relationship between antioxidant potency and the total phenolic groups content in each extract, and Methanolic extracts are more potent as scavengers of peroxyl and superoxide radicals than the ethyl ether extracts.
Journal ArticleDOI

Antioxidant properties of proanthocyanidins of Uncaria tomentosa bark decoction: a mechanism for anti-inflammatory activity

TL;DR: Results provide evidence for an antioxidant mechanism underlying the anti-inflammatory activity of cat's claw and support some of the biological effects of proanthocyanidins, more exactly its antioxidant and radical scavenging activities.
Journal ArticleDOI

Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment

TL;DR: The aim of this review is to highlight the progress in the discovery of potent and selective small molecule BACE1 inhibitors over the past decade.
Journal ArticleDOI

Cyanidin-3-glucoside suppresses cytokine-induced inflammatory response in human intestinal cells: comparison with 5-aminosalicylic acid.

TL;DR: Taking into account the high concentrations of dietary anthocyanins potentially reached in the gastrointestinal tract, cyanidin-3-glucoside may be envisaged as a promising nutraceutical giving complementary benefits in the context of inflammatory bowel disease.